Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_assertion type Assertion NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_head.
- NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_assertion description "[Of 17 enrolled patients, 11 were treated with different doses of L-DOPA; in this group, we found that the levels of two spots, corresponding to ATP synthase subunit ? and proteasome subunit ? type-2, correlated linearly with the L-DOPA daily dose.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_provenance.
- NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_assertion evidence source_evidence_literature NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_provenance.
- NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_assertion SIO_000772 22815142 NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_provenance.
- NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_assertion wasDerivedFrom befree-20150227 NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_provenance.
- NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_assertion wasGeneratedBy ECO_0000203 NP651538.RAvHurRw0BeKHY2cMinL7kMoC2IZCJbU5VmP4vV-Jzw4Y130_provenance.